Christopher R Gordon

Christopher R Gordon has an estimated net worth of $17.6 Billion. This is based on reported shares across multiple companies, which include HCA Holdings, Inc., Quintiles Transnational Holdings Inc., Acadia Healthcare Company, Inc., Aveanna Healthcare Holdings, Inc., Surgery Partners, Inc., Cerevel Therapeutics Holdings, Inc., SUNGARD CAPITAL CORP, SUNGARD CAPITAL CORP II, and KESTRA MEDICAL TECHNOLOGIES, LTD..

2020 was Christopher R Gordon's most active year for acquiring shares with 3 total transactions. Christopher R Gordon's most active month to acquire stocks was the month of May. 2013 was Christopher R Gordon's most active year for disposing of shares, totalling 6 transactions. Christopher R Gordon's most active month to dispose stocks was the month of July. 2023 saw Christopher R Gordon paying a total of $124,999,986.12 for 5,497,114 shares, this is the most they've acquired in one year. In 2013 Christopher R Gordon cashed out on 46,744,363 shares for a total of $1,875,511,598.53, their largest year based on trade value.